PharmaCyte Biotech, Inc. Common Stock (PMCB)

$0.71 +1.43%
EARNINGS ANALYTICS
search

PharmaCyte Biotech, Inc. Common Stock (PMCB) has only 1 recorded earnings event on file, so its post-earnings track record is limited. Its biggest recorded post-earnings gain was -0.42% (Jul 11, 2022) and its biggest decline was -0.42% (Jul 11, 2022).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

1

Avg Abs. Movement

±0.42%

Positive %

0.0%

Negative %

100.0%

Historical Earnings Statistics

Date Timing Open High Close Volume Movement % SEC Filing
Jul 11, 2022 ☽ POST $2.35 $2.42 $2.40 2,813 -0.42% open_in_new
event

Earnings Count

1

Total earnings in dataset

trending_up

Avg Abs. Movement

±0.42%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

Frequently asked about PMCB earnings

How much does PMCB stock move after earnings? expand_more

Over 1 reports, PMCB has moved an average of ±0.42% the session after earnings, closing higher 0.0% of the time.

What was PMCB's biggest post-earnings move? expand_more

PMCB's largest post-earnings gain on record was -0.42% on Jul 11, 2022, and its largest decline was -0.42% on Jul 11, 2022.

Where can I find PharmaCyte Biotech, Inc. Common Stock's SEC filings? expand_more

All of PharmaCyte Biotech, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers